Skip to content

Research paper

Role of magnesium supplementation in the treatment of depression: A randomized clinical trial

PLoS ONE
Q1
Jun 2017
Citations: 113
Influential: 5
Interventional (Human) Studies
84

Study answer

What this study found

Magnesium chloride improved depressive and anxiety symptoms versus control and was well tolerated. The primary PHQ-9 outcome showed a net improvement of -6.0 points (95% CI -7.9, -4.2; P<0.001), and the GAD-7 showed a net improvement of -4.5 points (95% CI -6.6, -2.4; P<0.001). During magnesium treatment, PHQ-9 scores fell by -4.3 points versus -0.1 during control, and GAD-7 scores fell by -3.9 points versus +0.8 during control. Adherence by pill count was 83% in the immediate group and 82% in the delayed group; most adverse effects were not increased, although headache was slightly less…

Study & population
Randomized clinical trial in adults with mild-to-moderate depression treated in outpatient primary care clinics at a single academic medical center in the United States.
Intervention
Oral magnesium chloride was given as four 500 mg tablets daily, providing 248 mg elemental magnesium per day for 6 weeks.
Key limitation
The study was modest in size, with 62 and 64 participants in the active treatment sequences, and used relatively short 6-week treatment periods.
View sourceOpen PDF

Original abstract

Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and depression, yet its role in symptom management is …